{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,3,26]],"date-time":"2025-03-26T19:26:34Z","timestamp":1743017194307,"version":"3.40.3"},"publisher-location":"New York, NY","reference-count":24,"publisher":"Springer New York","isbn-type":[{"type":"print","value":"9781493986293"},{"type":"electronic","value":"9781493986309"}],"license":[{"start":{"date-parts":[[2018,1,1]],"date-time":"2018-01-01T00:00:00Z","timestamp":1514764800000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2018]]},"DOI":"10.1007\/978-1-4939-8630-9_16","type":"book-chapter","created":{"date-parts":[[2018,7,23]],"date-time":"2018-07-23T09:28:03Z","timestamp":1532338083000},"page":"279-286","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Insights in Organometallic Synthesis of Various Adamantane Derivatives with Sigma Receptor-Binding Affinity and Antiproliferative\/Anticancer Activity"],"prefix":"10.1007","author":[{"given":"Ioannis","family":"Papanastasiou","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2018,7,24]]},"reference":[{"issue":"5","key":"16_CR1","doi-asserted-by":"publisher","first-page":"3516","DOI":"10.1021\/cr100264t","volume":"113","author":"L Wanka","year":"2013","unstructured":"Wanka L, Iqbal K, Schreiner PR (2013) The lipophilic bullet hits the targets: medicinal chemistry of adamantane derivatives. Chem Rev 113(5):3516\u20133604. \nhttps:\/\/doi.org\/10.1021\/cr100264t","journal-title":"Chem Rev"},{"issue":"29","key":"16_CR2","doi-asserted-by":"publisher","first-page":"3245","DOI":"10.2174\/0929867323666160525114026","volume":"23","author":"K Spilovsk","year":"2016","unstructured":"Spilovsk K, Zemek F, Korabecny J et al (2016) Adamantane \u2013 a lead structure for drugs in clinical practice. Curr Med Chem 23(29):3245\u20133266. \nhttps:\/\/doi.org\/10.2174\/0929867323666160525114026","journal-title":"Curr Med Chem"},{"issue":"1","key":"16_CR3","doi-asserted-by":"publisher","first-page":"79","DOI":"10.4155\/fmc.10.279","volume":"3","author":"S Narayanan","year":"2010","unstructured":"Narayanan S, Bhat R, Mesangeau C et al (2010) Early development of sigma-receptor ligands. Fut Med Chem 3(1):79\u201394. \nhttps:\/\/doi.org\/10.4155\/fmc.10.279","journal-title":"Fut Med Chem"},{"key":"16_CR4","doi-asserted-by":"publisher","first-page":"78","DOI":"10.1016\/j.cca.2014.05.004","volume":"436","author":"MJ Akhtar","year":"2014","unstructured":"Akhtar MJ, Ahamed M, Alhadlaq HA et al (2014) Targeted anticancer therapy: overexpressed receptors and nanotechnology. Clin Chim Acta 436:78\u201392","journal-title":"Clin Chim Acta"},{"issue":"10","key":"16_CR5","doi-asserted-by":"publisher","first-page":"2703","DOI":"10.1016\/j.bbamem.2014.08.022","volume":"1848","author":"A Van Waarde","year":"2015","unstructured":"Van Waarde A, Rybczynska AA, Ramakrishnan NK et al (2015) Potential applications for sigma receptor ligands in cancer diagnosis and therapy. Biochim Biophys Acta 1848(10):2703\u20132714. \nhttps:\/\/doi.org\/10.1016\/j.bbamem.2014.08.022","journal-title":"Biochim Biophys Acta"},{"issue":"2","key":"16_CR6","doi-asserted-by":"publisher","first-page":"129","DOI":"10.1016\/0304-3940(93)90362-O","volume":"163","author":"J Kornhuber","year":"1993","unstructured":"Kornhuber J, Schoppmeyer K, Riederer P (1993) Affinity of 1-amino- adamantanes for the binding site in post-mortem human frontal cortex. Neurosci Lett 163(2):129\u2013131. \nhttps:\/\/doi.org\/10.1016\/0304-3940(93)90362-O","journal-title":"Neurosci Lett"},{"issue":"6","key":"16_CR7","doi-asserted-by":"publisher","first-page":"1503","DOI":"10.1016\/S0968-0896(00)00072-9","volume":"8","author":"G Ronsisvalle","year":"2000","unstructured":"Ronsisvalle G, Marrazzo A, Prezzavento O et al (2000) Substituted 1-phenyl-2-cyclopropyl-methylamines with high affinity and selectivity for sigma sites. Bioorg Med Chem 8(6):1503\u20131513. \nhttps:\/\/doi.org\/10.1016\/S0968-0896(00)00072-9","journal-title":"Bioorg Med Chem"},{"key":"16_CR8","doi-asserted-by":"publisher","first-page":"123","DOI":"10.1016\/S0014-2999(02)02646-8","volume":"456","author":"B Bourrie","year":"2002","unstructured":"Bourrie B, Bribes E, De Nys N et al (2002) SSR125329A, a high affinity sigma receptor ligand with potent anti-inflammatory properties. Eur J Pharmacol 456:123\u2013131. \nhttps:\/\/doi.org\/10.1016\/S0014-2999(02)02646-8","journal-title":"Eur J Pharmacol"},{"key":"16_CR9","doi-asserted-by":"publisher","first-page":"200","DOI":"10.1016\/j.ejphar.2006.02.026","volume":"536","author":"C Bucolo","year":"2006","unstructured":"Bucolo C, Marrazzo A, Ronsisvalle S et al (2006) A novel adamantane derivative attenuates retinal ischemia\u2013reperfusion damage in the rat retina through \u03c31 receptors. Eur J Pharmacol 536:200\u2013203. \nhttps:\/\/doi.org\/10.1016\/j.ejphar.2006.02.026","journal-title":"Eur J Pharmacol"},{"key":"16_CR10","doi-asserted-by":"publisher","first-page":"5289","DOI":"10.1016\/j.bmcl.2011.07.028","volume":"21","author":"SD Banister","year":"2011","unstructured":"Banister SD, Yoo DT, Wern Chua S et al (2011) N-Arylalkyl-2-azaadamantanes as cage-expanded polycarbocyclic sigma (\u03c3) receptor ligands. Bioorg Med Chem Lett 21:5289\u20135292. \nhttps:\/\/doi.org\/10.1016\/j.bmcl.2011.07.028","journal-title":"Bioorg Med Chem Lett"},{"key":"16_CR11","doi-asserted-by":"publisher","first-page":"10241","DOI":"10.1021\/jm3013008","volume":"55","author":"S Riganas","year":"2012","unstructured":"Riganas S, Papanastasiou I, Foscolos GB et al (2012) New adamantane phenylalkylamines with \u03c3-receptor binding affinity and anticancer activity, associated with putative antagonism of neuropathic pain. J Med Chem 55:10241\u201310261. \nhttps:\/\/doi.org\/10.1021\/jm3013008","journal-title":"J Med Chem"},{"key":"16_CR12","doi-asserted-by":"publisher","first-page":"3323","DOI":"10.1016\/j.bmc.2012.03.038","volume":"20","author":"S Riganas","year":"2012","unstructured":"Riganas S, Papanastasiou I, Foscolos GB et al (2012) Synthesis, \u03c31, \u03c32-receptors binding affinity and antiproliferative action of new C1-substituted adamantanes. Bioorg Med Chem 20:3323\u20133331. \nhttps:\/\/doi.org\/10.1016\/j.bmc.2012.03.038","journal-title":"Bioorg Med Chem"},{"key":"16_CR13","doi-asserted-by":"publisher","first-page":"569","DOI":"10.2174\/157340612801216201","volume":"8","author":"S Riganas","year":"2012","unstructured":"Riganas S, Papanastasiou I, Foscolos GB et al (2012) New adamantane derivatives with sigma affinity and antiproliferative activity. Med Chem 8:569\u2013586. \nhttps:\/\/doi.org\/10.2174\/157340612801216201","journal-title":"Med Chem"},{"key":"16_CR14","doi-asserted-by":"publisher","first-page":"281","DOI":"10.1016\/j.ejmech.2015.02.021","volume":"93","author":"C Fytas","year":"2015","unstructured":"Fytas C, Zoidis G, Tsotinis A et al (2015) Novel 1-(2-aryl-2-adamantyl)piperazine derivatives with antiproliferative activity. Eur J Med Chem 93:281\u2013290. \nhttps:\/\/doi.org\/10.1016\/j.ejmech.2015.02.021","journal-title":"Eur J Med Chem"},{"key":"16_CR15","first-page":"47","volume":"18","author":"G Fytas","year":"1989","unstructured":"Fytas G, Kolocouris N, Foscolos GB, Pouli N (1989) Aminoethers de quelques aryladamantanols. Chimika Chronika New Ser 18:47\u201357","journal-title":"Chimika Chronika New Ser"},{"issue":"9","key":"16_CR16","doi-asserted-by":"publisher","first-page":"3021","DOI":"10.1021\/jo00009a018","volume":"56","author":"KT Liu","year":"1991","unstructured":"Liu KT, Sheu HC (1991) Solvolysis of 2-aryl-2-chloroadamantanes. A new Y scale benzylic chlorides. J Org Chem 56(9):3021\u20133025. \nhttps:\/\/doi.org\/10.1021\/jo00009a018","journal-title":"J Org Chem"},{"issue":"9","key":"16_CR17","doi-asserted-by":"publisher","first-page":"1408","DOI":"10.3390\/molecules22091408","volume":"22","author":"M-O Georgiadis","year":"2017","unstructured":"Georgiadis M-O, Karoutzou O, Foscolos A-S, Papanastasiou I (2017) Sigma receptor (\u03c3R) ligands with antiproliferative and anticancer activity. Molecules 22(9):1408. \nhttps:\/\/doi.org\/10.3390\/molecules22091408","journal-title":"Molecules"},{"key":"16_CR18","first-page":"45","volume-title":"Sigma receptors","author":"BR De Costa","year":"1994","unstructured":"De Costa BR, He X (1994) Structure\u2013activity relationships and evolution of \u03c3 receptor ligands. In: Itzhak Y (ed) Sigma receptors. Academic Press, London, pp 45\u2013111"},{"key":"16_CR19","doi-asserted-by":"publisher","first-page":"1966","DOI":"10.1007\/s00044-013-0798-7","volume":"23","author":"I Papanastasiou","year":"2014","unstructured":"Papanastasiou I, Tsotinis A, Kolocouris N et al (2014) New aminoadamantane derivatives with antiproliferative activity. Med Chem Res 23:1966\u20131975. \nhttps:\/\/doi.org\/10.1007\/s00044-013-0798-7","journal-title":"Med Chem Res"},{"issue":"5","key":"16_CR20","doi-asserted-by":"publisher","first-page":"319","DOI":"10.2174\/157017861205150509202419","volume":"12","author":"I Papanastasiou","year":"2015","unstructured":"Papanastasiou I, Riganas S, Foscolos GB et al (2015) Synthesis and cytotoxicity of 4-(2-Adamantyl)phenylalkylamines. Lett Org Chem 12(5):319\u2013323. \nhttps:\/\/doi.org\/10.2174\/157017861205150509202419","journal-title":"Lett Org Chem"},{"issue":"3","key":"16_CR21","doi-asserted-by":"publisher","first-page":"171","DOI":"10.2174\/1570178613666160104233856","volume":"13","author":"A Koperniku","year":"2016","unstructured":"Koperniku A, Foscolos A-S, Papanastasiou I et al (2016) 4-(1-Adamantyl)phenyl alkylamines with potential anti- proliferative activity. Lett Org Chem 13(3):171\u2013176. \nhttps:\/\/doi.org\/10.2174\/1570178613666160104233856","journal-title":"Lett Org Chem"},{"key":"16_CR22","unstructured":"Papaconstantinou-Garoufalias S, Foscolos GB, Costakis E (1984) Adamantane analogs of diphenhydramine. Chim Chron, New series, 13:225\u2013237"},{"issue":"5","key":"16_CR23","doi-asserted-by":"publisher","first-page":"1161","DOI":"10.1002\/cber.19600930527","volume":"93","author":"H Stetter","year":"1960","unstructured":"Stetter H, Rauscher E (1960) Uber verbindungen mit urotropin-struktur XVII. Zur kenntnis der adamantan-carbos\u00e4ure-(I). Chem Ber 93(5):1161\u20131166. \nhttps:\/\/doi.org\/10.1002\/cber.19600930527","journal-title":"Chem Ber"},{"issue":"1","key":"16_CR24","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1021\/cr60125a002","volume":"40","author":"J Cason","year":"1947","unstructured":"Cason J (1947) The use of organocadmium reagents for the preparation of ketones. Chem Rev 40(1):15\u201332. \nhttps:\/\/doi.org\/10.1021\/cr60125a002","journal-title":"Chem Rev"}],"container-title":["Methods in Molecular Biology","Rational Drug Design"],"original-title":[],"link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/978-1-4939-8630-9_16","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2018,12,5]],"date-time":"2018-12-05T12:16:11Z","timestamp":1544012171000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/978-1-4939-8630-9_16"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018]]},"ISBN":["9781493986293","9781493986309"],"references-count":24,"URL":"https:\/\/doi.org\/10.1007\/978-1-4939-8630-9_16","relation":{},"ISSN":["1064-3745","1940-6029"],"issn-type":[{"type":"print","value":"1064-3745"},{"type":"electronic","value":"1940-6029"}],"subject":[],"published":{"date-parts":[[2018]]}}}